You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

C16-174

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IL- 6 Gene Single Nucleotide Polymorphism asIndicator of

Completed
  • Covid19
  • interleuken 6 level measurment
  • Interleukin-6 Gene-174C detection
  • Tanta, El Gharbyia, Egypt
    Bsant Safwat Kasem
May 1, 2022

Dental Caries Trial in Kalispell, Bedford, Irving (27.2 mg C16G2 Varnish, 13.6 mg C16G2 Varnish, 54.4 mg C16G2 Varnish)

Completed
Has Results
  • Dental Caries
  • C16G2 Varnish
  • Placebo Varnish
  • Kalispell, Montana
  • +2 more
Dec 8, 2022

Dental Caries Trial in Kalispell, Bedford, Irving (C16G2 Strip, Placebo Strip)

Completed
Has Results
  • Dental Caries
  • C16G2 Strip
  • Placebo Strip
  • Kalispell, Montana
  • +2 more
Dec 9, 2022

Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma, Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 21, 2022

24-hour Cold and Heat Exposure on Factors Influencing Food

Recruiting
  • Eating Habit
  • +2 more
  • Heat exposure (32°C)
  • +2 more
  • Brétigny-sur-Orge, France
    Institut de Recherche Biomédicale des Armées
Dec 8, 2022

Pertussis/Whooping Cough Trial in Southampton (Bordetella pertussis B1917, Azithromycin Pill)

Recruiting
  • Pertussis/Whooping Cough
  • Bordetella pertussis B1917
  • Azithromycin Pill
  • Southampton, Hampshire, United Kingdom
    NIHR Clinical Research Facility
Apr 26, 2023

Melanoma, Renal Cell Carcinoma Trial in Hull (Zirconium 89Zr crefmirlimab berdoxam)

Recruiting
  • Melanoma
  • Renal Cell Carcinoma
  • Zirconium 89Zr crefmirlimab berdoxam
  • Hull, United Kingdom
    Castle Hill Hospital
Feb 15, 2023

Immune Response in Patients With Hepatitis B and C Infection

Recruiting
  • Hepatitis B
  • Hepatitis C
    • Basildon, Essex, United Kingdom
      Basildon Hospital
    Apr 5, 2022

    Bipolar Depression Trial in Rochester, Mason (Mydayis Extended-Release Capsule, Placebo)

    Recruiting
    • Bipolar Depression
    • Mydayis Extended-Release Capsule
    • Placebo
    • Rochester, Minnesota
    • +1 more
    Nov 9, 2022

    Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma

    Not yet recruiting
    • Double-Expressor Lymphoma
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    Gastroenteritis Norovirus Trial in Cincinnati (Norovirus GII.4 Challenge Pool)

    Recruiting
    • Gastroenteritis Norovirus
    • Norovirus GII.4 Challenge Pool
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center - Infectious Disea
    Aug 18, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial

    Active, not recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Jacksonville, Florida
    • +11 more
    Jan 12, 2023

    People Who Have Genetic Changes and Features of Autism: Simons

    Recruiting
    • 16P11.2 Deletion Syndrome
    • +184 more
      • New York, New York
      • +1 more
      Jan 6, 2023

      Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)

      Completed
      Has Results
      • Lymphoblastic Lymphoma
      • San Diego, California
      • +1 more
      Jun 7, 2022

      Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jul 21, 2023

      B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
      • Bone Marrow Aspiration and Biopsy
      • +7 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 11, 2022

      Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

      Withdrawn
      • Recurrent Diffuse Large B-Cell Lymphoma
      • +9 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +5 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

      Recruiting
      • Hematological Malignancy
      • Ningbo, Zhejiang, China
        The Affiliated People's Hospital of Ningbo University.
      Aug 18, 2022

      Advanced Solid Tumor Trial in Houston, San Antonio (MRTX849, Palbociclib)

      Recruiting
      • Advanced Solid Tumor
      • Houston, Texas
      • +1 more
      Feb 18, 2022

      Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

      Completed
      Has Results
      • Breast Cancer Stage IV
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Oct 21, 2022

      Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

      Completed
      Has Results
      • Acute Lymphoblastic Leukemia
      • Lymphoblastic Lymphoma
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jun 18, 2022

      Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

      Recruiting
      • Recurrent Acute Lymphoblastic Leukemia
      • +10 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 21, 2022

      Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

      Completed
      Has Results
      • Diffuse Large Cell Lymphoma Relapsed/Refractory
      • San Francisco, California
        University of California, San Francisco
      Jun 5, 2022

      Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent

      Recruiting
      • Clonal Cytopenia of Undetermined Significance
      • +6 more
      • Ascorbic Acid
      • +12 more
      • Scottsdale, Arizona
      • +4 more
      May 26, 2022

      Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

      Recruiting
      • Recurrent Hodgkin Lymphoma
      • Refractory Hodgkin Lymphoma
      • Basiliximab
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Jun 16, 2022